These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 29393163

  • 21. The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
    Yang W, Liu Q, Lin G, Zhang B, Cao H, Zhao Y, Xia L, Feng F, Xiong Z, Hu J, Ye Y, Tao K, Zhang P.
    J Surg Oncol; 2021 Dec; 124(7):1128-1135. PubMed ID: 34324197
    [Abstract] [Full Text] [Related]

  • 22. Imatinib Pharmacokinetics in a Large Observational Cohort of Gastrointestinal Stromal Tumour Patients.
    Farag S, Verheijen RB, Martijn Kerst J, Cats A, Huitema AD, Steeghs N.
    Clin Pharmacokinet; 2017 Mar; 56(3):287-292. PubMed ID: 27435281
    [Abstract] [Full Text] [Related]

  • 23. Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.
    Koo DH, Ryu MH, Ryoo BY, Beck MY, Na YS, Shin JG, Lee SS, Kim EY, Kang YK.
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):173-82. PubMed ID: 25417047
    [Abstract] [Full Text] [Related]

  • 24. Key messages from the BFR14 trial of the French Sarcoma Group.
    Patrikidou A, Le Cesne A.
    Future Oncol; 2017 Feb; 13(3):273-284. PubMed ID: 27624671
    [Abstract] [Full Text] [Related]

  • 25. Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors.
    Blay JY, Pérol D, Le Cesne A.
    Ann Oncol; 2012 Jul; 23(7):1659-65. PubMed ID: 22357253
    [Abstract] [Full Text] [Related]

  • 26. S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors.
    Blanke CD, Rankin C, Corless C, Eary JF, Mulder K, Okuno SH, George S, Heinrich M.
    Oncologist; 2015 Dec; 20(12):1353-4. PubMed ID: 26576593
    [Abstract] [Full Text] [Related]

  • 27. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink HH, Bonenkamp JJ, van der Graaf WT, de Wilt JH.
    Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
    [Abstract] [Full Text] [Related]

  • 28. Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?
    Sutton TL, Billingsley KG, Johnson AJ, Corless CL, Blanke CD, Heinrich MC, Mayo SC.
    J Surg Oncol; 2024 Jul; 130(1):40-46. PubMed ID: 38924626
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor.
    Wu X, Li J, Xu W, Gao J, Li Y, Shen L.
    Future Oncol; 2018 Jul; 14(17):1721-1729. PubMed ID: 29969914
    [Abstract] [Full Text] [Related]

  • 34. Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?
    Eriksson M, Reichardt P, Sundby Hall K, Schütte J, Cameron S, Hohenberger P, Bauer S, Leinonen M, Reichardt A, Rejmyr Davis M, Alvegård T, Joensuu H.
    Eur J Cancer; 2016 May; 59():128-133. PubMed ID: 27033260
    [Abstract] [Full Text] [Related]

  • 35. Role of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry.
    Sato S, Tsujinaka T, Masuzawa T, Yamamoto K, Takahashi T, Yamashita Y, Fujita J, Takagi M, Hirota S, Nishida T.
    Surg Today; 2017 Jan; 47(1):58-64. PubMed ID: 27194124
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib.
    Schindler CG, Armbrust T, Gunawan B, Langer C, Füzesi L, Ramadori G.
    Z Gastroenterol; 2005 Mar; 43(3):267-73. PubMed ID: 15765299
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
    Casali PG, Zalcberg J, Le Cesne A, Reichardt P, Blay JY, Lindner LH, Judson IR, Schöffski P, Leyvraz S, Italiano A, Grünwald V, Pousa AL, Kotasek D, Sleijfer S, Kerst JM, Rutkowski P, Fumagalli E, Hogendoorn P, Litière S, Marreaud S, van der Graaf W, Gronchi A, Verweij J, European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group.
    J Clin Oncol; 2017 May 20; 35(15):1713-1720. PubMed ID: 28362562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.